Drug use: confronting a latent problem

Authors

Keywords:

street drugs, substance-related disorders, drug users, cannabis, cocaine, amphetamine, methamphetamine, risk factors, Cuba.

Abstract

There are some situations that put Cuba at risk in terms of drug use, including the increase in tourism, relations with countries that have high rates of use, the geographic location in drug trafficking corridors, and the high prevalence of portering drugs. In this regard, the National Health System must be prepared to prevent the problem and care for those affected, so it is necessary to maintain updated information on risk factors and the main products used by consumers. In the present bibliographical review on the subject, it is sought to draw the attention of health workers in this regard, data on the magnitude of the problem are offered and elements of its background are addressed, as well as drugs classification of, the risk factors associated with its use and the legal bases for its control in Cuba.

Downloads

Download data is not yet available.

Author Biographies

Luis Eugenio Valdés García, Instituto Finlay de Vacunas. La Habana

Doctor en Ciencias Medicas, Master en enfermedades Infecciosas, Profesor titular de Epidemiologia, Investigador Auxiliar.

Trabajo en la Universidad Walter Sisulu impartiendo Salud Publica en Pre y Post-grado. 

Ariadna Domínguez Mateos, Hospital Ginecoobstétrico Docente Norte Tamara Bunke Bider. Santiago de Cuba

Hospital Materno Tamara BunkeBidder Santiago de Cuba

 

References

1. United Nations Office on Drugs and Crime. World Drug Report 2020. Viena: UNODC; 2020.

2. United Nations Office on Drugs and Crime. Informe Mundial sobre Drogas 2021: los efectos de la pandemia aumentan los riesgos de las drogas, mientras los jóvenes subestiman los peligros del cannabis. Viena: UNODC; 2021.

3. Milián Gerardo Y, Gálvez Cabrera E, Pita Alcorta C, Rosales Domínguez O. Factores de riesgo para el consumo de drogas ilícitas. Rev Cubana Med Gen Integr. 2005 [citado 02/03/2022];21(5-6). Disponible en: http://scielo.sld.cu/pdf/mgi/v21n5-6/mgi135-605.pdf

4. Organización Mundial de la Salud. Glosario de términos de alcohol y drogas. Madrid: Ministerio de Sanidad y Consumo; 2008. p. 34 [citado 02/03/2022]. Disponible en: http://apps.who.int/iris/bitstream/handle/10665/44000/9241544686_spa.pdf?sequence=1

5. Psicología-Online. Badia A. Clasificación de las drogas - OMS y sus efectos. 2019 [citado 02/03/2022]. Disponible en: https://www.psicologia-online.com/clasificacion-de-las-drogas-oms-y-sus-efectos-918.html

6. Oficina de las Naciones Unidas contra la Droga y el Delito. Drogas sintéticas y nuevas sustancias psicoactivas en América Latina y el Caribe 2021. Viena: UNODC; 2021 [citado 02/03/2022]. Disponible en: https://www.unodc.org/documents/scientific/21-02921_LAC_drug_assessment_S_ebook.pdf

7. Instituto sobre Alcoholismo y Farmacodependencia. ¿Qué es la adicción? San José: IAFA; 2018.

8. Tavera Romero S, Martínez Ruíz MJ. Prevención de las adicciones y promoción de conductas saludables: Guía para el Promotor de “Nueva Vida”. Ciudad de México: CONADIC; [ 20―].

9. Comisión Global de Políticas de Drogas. La clasificación de sustancias psicoactivas Cuando se dejó atrás la ciencia. Informe de 2019 [citado 01/08/2022]. Londres: IDPC; 2019. Disponible en: https://www.globalcommissionondrugs.org/wp-content/uploads/2019/06/2019Report_ESP_web.pdf

10. Chile. Ministerio del Interior y Seguridad Pública. Información sobre drogas. Pasta Base [citado 24/07/2022]. Disponible en: https://www.senda.gob.cl/informacion-sobre-drogas/conoce-mas-sobre-las-drogas/pasta-base/

11. Anta GB, Rodríguez Arenas MA, de la Fuente de Hoz L, Royuela Morales L. Emergency room admissions in cocaine users in Spanish hospitals: first evidences of acute complications related to crack use. Work Group for the Study of Emergencies from Psychostimulants. Med Clin (Barc). 1998 [citado 24/07/2022];111(2):49-55. Disponible en: https://pubmed.ncbi.nlm.nih.gov/9706586/

12. ccadicciones. Efectos y consecuencias del consumo de Crack. Roda de Berà 2021 [citado 01/08/2022]. Disponible en: https://www.ccadicciones.es/efectos-del-consumo-de-crack/

13. Aleteia. Fiz Pérez J. Los daños psicológicos de la dependencia de las drogas [citado 01/08/2022]. Dsiponible en: https://es.aleteia.org/2018/12/01/los-danos-psicologicos-de-la-dependencia-de-las-drogas/

14. National Institute on Drug Abuse. Abuso de la MDMA (éxtasis)-Reporte de investigación. Bethesda (MD): NIH; 2017 [citado 06/07/2022]. Disponible en: https://nida.nih.gov/es/download/1763/abuso-de-la-mdma-extasis-reporte-de-investigacion.pdf?v=ed31f85cd834fb29a9ea46f13a716177

15. O’Shea E. Éxtasis líquido: estructura, farmacología, efectos adversos y mecanismos de acción. Trastornos Adictivos. 2008 [citado 24/07/2022];10(3):190–4. Disponible en: https://www.elsevier.es/es-revista-trastornos-adictivos-182-articulo-extasis-liquido-estructura-farmacologia-efectos-13128594

16. National Institute on Drug Abuse. ¿Qué es la metanfetamina? National Institute on Drug Abuse. Bethesda (MD): NIH; 2022 [citado 06/07/2022]. Diponible en: https://nida.nih.gov/es/publicaciones/serie-de-reportes/abuso-y-adiccion-la-metanfetamina/que-es-la-metanfetamina

17. Corbin JA. Popper: qué es y cuáles son los efectos de esta droga. Drogas y adiciones. Psicología y Mente. 14 May 2017 [citado 06/07/2022]. Disponible en: https://psicologiaymente.com/drogas/popper

18. United Nations Office on Drugs and Crime. World Drug Report 2018. Viena: UNODC; 2018 [citado 17/05/2022]. https://www.unodc.org/wdr2018/prelaunch/WDR18_Booklet_1_EXSUM.pdf

19. Comisión Interamericana para el Control del Abuso de Drogas. Informe sobre el consumo de drogas en las Américas 2019. Washington D.C.: OEA; 2019 [citado 08/04/2022]. Disponible en: http://www.codajic.org/sites/default/files/sites/www.codajic.org/files/Informe%20Sobre%20el%20Consumo%20de%20Drogas%20en%20las%20Americas%20Resumen%20Ejecutivo%202019.pdf

20. Canada. Public Safety Canada. Canadian Alcohol and Drug Use Monitoring Survey. Summary of Results for 2011. Ottawa: CADUMS; 2011 [citado 17/05/2022]. Disponible en: https://www.publicsafety.gc.ca/lbrr/archives/cnmcs-plcng/cn30010-2011-eng.pdf

21. Herrera Batista A, Ruiz Candina H, Martínez Betancour A. Caracterización del consumo de drogas psicoactivas por jóvenes y adolescentes atendidos en el Centro de Deshabituación de Adolescentes del municipio Playa. Rev Cuban Invest Bioméd. 2014 [citado 17/05/2022]; 33(1):61-9. Disponible en: http://scielo.sld.cu/pdf/ibi/v33n1/ibi07114.pdf

22. Santana Macías L, Serrano Patten MC, Rosales Domínguez O; Amador Montejo J. Caracterización psicosocial y del consumo en adolescentes del Centro Comunitario de Salud Mental Plaza, 2015. Rev Hosp Psiq Hab. 2016 [citado 5/02/2021];13(1). Disponible en: https://www.medigraphic.com/pdfs/revhospsihab/hph-2016/hphs161c.pdf

23. Matos Gil AM. Sobre las Drogas… escucha primero. CUBAHORA. 2023 Abr [citado 5/02/2021]. Disponible en: https://www.cubahora.cu/sociedad/sobre-las-drogas-escucha-primero?reply_to=45823

24. Áreas Fernández F. Cuba: tolerancia cero ante amenaza global del narcotráfico. Granma. 1 Feb 2022 [citado 02/02/2022]. Disponible en: https://www.granma.cu/cuba/2022-02-01/cuba-tolerancia-cero-ante-amenaza-global-del-narcotrafico-01-02-2022-00-02-33

25. Cannabis sativa. En: Wikipedia. La Enciclopedia Libre [citado 06/02/2020]. Disponible en: https://es.wikipedia.org/wiki/Cannabis_sativa

26. McPartland JM. Cannabis Systematics at the Levels of Family, Genus, and Species. Cannabis Cannabinoid Res. 2018 [citado 06/02/2020];3(1):203-12. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225593/

27. Mohamed Ben A. Cannabinoids in medicine: A review of their therapeutic potential. J Ethnopharmacol. 2006;105(1–2):1-25.

28. Notas de Humo. Cómo saber si mi planta de marihuana es macho o hembra [citado 5/02/2021]. Disponible en: https://notasdehumo.com/sexo-marihuana/

29. Gaoni Y, Mechoulam R. Isolation, structure and partial synthesis of an active constituent of hashish. J Am Chem Soc. 1964; 86(8):1646-7.

30. Garrett Edward R, Hunt CA. Physicochemical properties, solubility and protein binding of Δ9 -Tetrahydrocannabinol. J. Pharm. Sci. 1974;63(7):1056-64.

31. Babayeva M, Fuzailov M, Rozenfeld P, Basu P. Marijuana compounds: A non- conventional therapeutic approach to epilepsy in children. J Addict Addictv Disord. 2014 [citado 19/02/2022];1(002):1-9. Disponible en: http://heraldopenaccess.us/article_pdf/2/marijuana-compounds-a-non-conventional-therapeutic-approach-to-epilepsy-in-children.pdf

32. Kozela E, Lev N, Kaushansky N, Eilam R, Rimmerman N, Levy R, et al. Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice. Br J Pharmacol. 2011 [citado 19/02/2022];163(7):1507-19. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165959/

33. Alchimia. Los terpenos de la marihuana y sus efectos; 2001-2023 [citado 08/02/2021]. Disponible en: https://www.alchimiaweb.com/blog/terpenos-marihuana-efectos/

34. Kalant H. Adverse effects of cannabis on health: an update of the literature since 1996. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28(5):849-63.

35. Macleod J, Oakes R, Copello A, Crome I, Egger M, Hickman M, et al. Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies. Lancet. 2004 [citado 08/05/2022];363:1579-88. Disponible en: http://www.pyramid-tech.net/images/drugwar/cannabis.pdf

36. Henquet C, Krabbendam L, Spauwen J, Kaplan C, Lieb R, Wittchen HU, et al. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ. 2005 [citado 08/05/2022];330(7481):11. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC539839/

37. World Health Organization. The health and social effects of nonmedical cannabis use. São Paulo: Clínica Gressus. 2016.

38. Borgelt LM, Franson KL, Nussbaum AM, Wang GS. The Pharmacologic and Clinical Effects of Medical Cannabis. Pharmacotherapy. 2013 [citado 08/05/2022];33(2):195-209. Disponible en: http://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.1187

39. SALUD180. Cinco usos médicos de la marihuana [actualizado; citado 04/07/2022]. Disponible en: https://www.salud180.com/jovenes/5-usos-medicos-de-la-mariguana

40. Brook JS, Kessler RC, Cohen P. The onset of marijuana use from preadolescence and early adolescence to young adulthood. Dev Psychopathol. 1999;11(4):901-14.

41. Van Etten ML, Anthony JC. Male-Female Differences in Transitions from First Drug Opportunity to First Use: Searching for Subgroup Variation by Age, Race, Region, and Urban Status. J Womens Health Gend Based Med. 2001 [citado 08/05/2022];10(8):797-804. Disponible en: https://deepblue.lib.umich.edu/bitstream/handle/2027.42/63334/15246090152636550.pdf?sequence=1&isAllowed=y

42. Evers KE, Paiva AL, Johnson JL, Cummins CO, Prochaska JO, Prochaska JM, et al. Results of a transtheorical model-based alcohol, tobacco and other drug intervention in middle schools. Addict Behav. 2012; 37(9):1009-18.

43. Newcomb MD, Maddahian E, Bentler PM. Risk factors for drug use among adolescents: concurrent and longitudinal analyses. Am J Public Health. 1986 [citado 09/03/2022];76(5):525-31. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1646592/pdf/amjph00268-0047.pdf

44. Duncan TE, Alpert A, Duncan SC, Hops H. Multilevel covariance structure analysis of sibling substance use and intrafamily conflict. Journal of Psychopathology & Behavioral Assessment. 1996;18(4):347-69.

45. Kessler RC, Angermeyer M, Anthony JC, de Graaf R, Demyttenaere K, Gasquet I, et al. Lifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organization’s World Mental Health Survey Initiative. World Psychiatry. 2007 [citado 09/03/2022];6(3):168-76. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2174588/

Downloads

Published

2023-04-29

How to Cite

1.
Valdés García LE, Domínguez Mateos A. Drug use: confronting a latent problem. MEDISAN [Internet]. 2023 Apr. 29 [cited 2025 Nov. 3];27(2):e4269. Available from: https://medisan.sld.cu/index.php/san/article/view/4269

Issue

Vol. 27 No. 2 (2023): MARZO-ABRIL

Section

Review articles

License

All the articles can be downloaded or read for free. The journal does not charge any amount of money to the authors for the reception, edition or the publication of the articles, making the whole process completely free. Medisan has no embargo period and it is published under the license of Creative Commons, International Non Commercial Recognition 4.0, which authorizes the copy, reproduction and the total or partial distribution of the articles in any format or platform, with the conditions of citing the source of information and not to be used for profitable purposes.